Edgewise Therapeutics (EWTX) Treasury Shares (2022 - 2025)

Edgewise Therapeutics has disclosed Treasury Shares across 4 years of filings, most recently posting $1.3 million for Q4 2025.

• Treasury Shares for Q4 2025 came in at $1.3 million, up 99.36% year-over-year; the trailing twelve-month figure through Dec 2025 was $1.3 million (up 99.36% YoY), and the FY2025 annual result was $1.3 million, up 99.36% from the prior year.
• Treasury Shares came in at $1.3 million for Q4 2025 at Edgewise Therapeutics, up from $639516.0 in the prior quarter.
• In the past five years, Treasury Shares ranged from a high of $1.3 million in Q4 2025 to a low of $177871.0 in Q4 2023.
• The 4-year median for Treasury Shares is $453545.5 (2022), against an average of $589978.5.
• Across the five-year window, Treasury Shares plunged 33.52% in 2023 and surged 259.54% in 2024, its largest moves.
• Edgewise Therapeutics' Treasury Shares stood at $267575.0 in 2022, then slumped by 33.52% to $177871.0 in 2023, then soared by 259.54% to $639516.0 in 2024, then jumped by 99.36% to $1.3 million in 2025.
• The last three Treasury Shares figures came in at $1.3 million (Q4 2025), $639516.0 (Q4 2024), and $177871.0 (Q4 2023), per Business Quant data.